Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Feasibility Study of Intermittent Fasting in Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma (CLL/SLL) Patients at BC Cancer- Victoria

NCT04626843 is registered in ClinicalTrials.gov with Eleah Stringer as lead sponsor.

NCT NCT04626843
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04626843 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Feasibility Study of Intermittent Fasting in Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma (CLL/SLL) Patients at BC Cancer- Victoria
Lead sponsor
Eleah Stringer
Phase
Phase 1
Overall status
Completed
Start date
February 3, 2021
Completion date
December 31, 2022
Enrollment
15 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diet habit, inflammation, intermittent fasting, leukemia, lymphocytic, chronic, lymphoma, small lymphocytic, neoplasms